$KPTI
Karyopharm Therapeutics Inc.
XNAS•Health Care•Pharmaceutical Preparations
$0.800
▲+66.67%+$0.320
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKaryopharm Therapeutics Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is KPTI up today? It is at $0.800 (+66.67%), and our scanner flagged it 97 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KPTI spikes, and full due diligence on KPTI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KPTI 97 times in the last 30 days. Create a free account to track $KPTI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
KPTI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 21 unusual-volume and momentum alerts on KPTI today, peaking at 254.3x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystOther Material Event, from an SEC filing. Read it →Across every filing on file, supply equal to 4967.5% of the tradeable float is in play - 4967.5% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $30.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Abate Kristin Officer | Sold (automatic/other) | -5K 0.02% of company | sold 20% | 19K | $2K at $0.340 | Oct 16, 26 |
Abate Kristin Officer | Sold (automatic/other) | -378 | sold 1.6% | 23K | $450 at $1.19 | Oct 1, 26 |
Abate Kristin Officer | Sold (automatic/other) | -19 | sold <0.1% | 24K | $38 at $2.02 | Sep 1, 26 |
Poulton Stuart Officer | Sold (automatic/other) | -189 | sold 0.2% | 95K | $1K at $7.10 | Jul 28, 26 |
Greene Barry E Director | Acquired (grant/award) | +16K 0.07% of company | added 100% | 16K | n/a | May 21, 26 |
Bohlin Garen G Director | Acquired (grant/award) | +16K 0.07% of company | added 100% | 19K | n/a | May 21, 26 |
Su Zhen Director | Acquired (grant/award) | +16K 0.07% of company | n/a | 16K | n/a | May 21, 26 |
Schor Chen Director | Acquired (grant/award) | +16K 0.07% of company | n/a | 16K | n/a | May 21, 26 |
Pakianathan Deepika Director | Acquired (grant/award) | +16K 0.07% of company | n/a | 16K | n/a | May 21, 26 |
Oliger Christy J. Director | Acquired (grant/award) | +16K 0.07% of company | n/a | 16K | n/a | May 21, 26 |
Mano Michael Officer | Sold (automatic/other) | -266 | sold 0.3% | 94K | $3K at $9.50 | May 14, 26 |
Paulson Richard A. Officer | Sold (automatic/other) | -2K | sold 0.8% | 270K | $21K at $9.50 | May 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
KPTI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 21 unusual-volume and momentum alerts on KPTI today, peaking at 254.3x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
KPTI last traded at $0.800, up 66.67% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Karyopharm Therapeutics Inc. (KPTI) is next expected to report earnings on Monday, November 2, 2026, about 5 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KPTI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KPTI 97 times in the last 30 days.
KPTI (Karyopharm Therapeutics Inc.) trades on XNAS, with a market cap of about $11M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KPTI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KPTI discussion
Sign in to ask a question or join the discussion.